search the site
About Us
Career Center
Store
Contact Us
Donate
Login
American Society of Addiction Medicine
Menu
Advocacy
Advocacy Main Page
Advocacy Committees & Councils
Advocacy Toolkits
Coalitions
Public Policy Statements
Take Action
Press Room
Education
CME Events
e-Learning Center
Live & Online CME
Educational Resources
Certification and MOC
Joint Provider CME
Membership
Join ASAM Today
Paths to Certification
Member Types & Dues
Benefits
Designations
Associate Membership
Residents, Fellows & Students
Awards & Scholarships
State Chapters
Resources
Definition of Addiction
Publications
Clinical Resources
The ASAM Criteria
Patient Resources
Practice Management
Other Resources
Level of Care Certification
CME Events
PUBLIC POLICY STATEMENTS
Policy Categories
Featured Policies
All Policies
White Papers
Archives
Children and Addiction
Confidentiality and Patient Protection
Criminal Justice Policy
Definitions and Terminology
Ethics
Infectious Diseases and Addiction
Insurance Coverage and Payment for Addiction Treatment
Licensed Professionals with Addictive Illness
Marijuana
National Drug Policy
Nicotine
Opioids
Practice of Addiction Medicine
Prevention
Public Health
Recovery
Research and Evaluation
Women and Addiction
Featured Policy Statements
Prescription Drug Monitoring Programs (PDMPs)
April 11, 2018
(?)
Marijuana, Cannabinoids and Legalization
September 21, 2015
(?)
Prescription Drug Monitoring Programs (PDMPs)
April 11, 2018
(?)
Morphine Equivalent Units/Morphine Milligram Equivalents
October 8, 2016
(?)
Patient Review and Restriction (PRR) Programs
April 12, 2016
(?)
Marijuana, Cannabinoids and Legalization
September 21, 2015
(?)
Core Benefit for Primary Care and Specialty Treatment and Prevention of Alcohol, Nicotine and Other Drug Abuse and Dependence
April 1993
(?)